Page 2 - Intel Mobileye News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mercedes-Benz has taken a major step forward in its efforts to produce self-driving cars, partnering with Luminar to include the latter's Iris lidar technology

Intel says the move will unlock the value of Mobileye for its shareholders by creating a separate publicly traded company and will build on Mobileye’s successful track record and serve its expanded market.

Oxford, United Kingdom, November 29th, 2021 — Imperas Software Ltd., the leader in RISC-V simulation solutions, today announced with MIPS, Inc., the processor technology company focused on the commercialization of RISC-based processor architectures and IP cores, the continuation and extension to the long-standing relationship with simulation and verification support for RISC-V. Since 2010, MIPS has partnered with Imperas…

Operator Hello, and welcome to the Veoneer Q2 Report 2021 Call. [Operator Instructions] Today, I'm pleased to present Thomas Jonsson. Please go ahead with your meeting. Thomas Jonsson -- Executive Vice President, Communications & Investor Relations Thank you very much, Ness, and welcome everyone to our second quarter 2021 earnings conference call and webcast presentation. Here in Stockholm, we have our Chairman, President and CEO, Jan Carlson; our Chief Financial Officer, Ray Pekar; and myself, Thomas Jonsson, Communications and IR. During the call today, Jan will comment on our current busi...

Microchip Shortages Potentially Impacting Switch Covered In '60 Minutes' Report In recent months a topic that has come up a fair bit in gaming has been manufacturing issues; it impacted Nintendo to a degree in the middle of 2020 but the company nevertheless produced enough stock to report incredible hardware sales. Despite this, however, Nintendo has continued to highlight the risks around supplies and meeting demand; the consensus is that the company is in a decent position to avoid the worst of issues around production, but it's unlikely to be completely immune. The headlines have primarily...